◆ 会议时间：2026年2月19-21日
◆ 会议地点：美国 棕榈沙漠
◆ 会议简介：
2026年多学科头颈癌研讨会将于2026年2月19-21日在美国棕榈沙漠举行。
多学科头颈部癌症研讨会由美国放射肿瘤学会(ASTRO)、美国临床肿瘤学会(ASCO)、美国头颈学会(AHNS)、癌症免疫治疗学会(SITC)四个学会联合举办，将为与会者提供有关头颈部癌症最新的多学科治疗、最新的临床研究、新的治疗策略、支持性治疗、科学突破和毒性缓解等信息，预计有来自世界各地的近1000名专业人士参加会议。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）.
2026 Multidisciplinary Head and Neck Cancers Symposium
Date:
February 19-21, 2026
Venue:
In Person: JW Marriott Desert Springs, Palm Desert, California, USA
Online: Live Virtual Meeting
Meeting Theme: Advancing Patient-Centered Care Through Innovative Team Science
This premier two-and-a-half-day multidisciplinary symposium brings together radiation oncologists, medical oncologists, surgeons and other specialists to share the latest evidence-based practices in head and neck cancer care. Through interactive case discussions, educational sessions and oral abstract presentations, attendees will gain practical insights and engage in meaningful collaboration aimed at improving patient outcomes and advancing multidisciplinary treatment approaches. See below to learn more about submitting abstracts for this meeting!
摘要-Abstracts
The 2026 Call for Abstracts site is now open through Wednesday, October 8, 2025, at 11:59 p.m. Pacific Time.
Fee: $75 per submission (non-refundable)
点此提交摘要>>>Submit Abstract>>>
在提交摘要之前，请仔细阅读提交指南。
Notification of acceptance will be sent in late November 2025 to the presenting author only.
Late-breaking abstract submissions will be accepted December 18, 2025 through January 6, 2026.
Submission Topics
Abstracts should be submitted in the most appropriate category. A list of submission categories is listed below and at the online submission site. Planning committees have the right to recategorize any abstract as deemed appropriate. If your abstract is a trial in progress, please indicate this on the abstract submission site.
2026 Abstract Topic Categories:
- Basic and Translational Immunology
- Definitive Management of Head and Neck Squamous Cell Carcinoma
- Epidemiology and Prevention
- Imaging, Physics and Pathology
- Management of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
- Molecular Biology, Therapeutics and Biomarkers
- Non-mucosal Malignancies of Head and Neck (thyroid, sarcomas, salivary gland, sinus cancers and non-melanoma skin cancers)
- Toxicity, Quality of Life, Survivorship, Costs of Care and Integrative Medicine
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
